Stock Price
1.48
Daily Change
-0.03 -1.99%
Monthly
-5.13%
Yearly
-17.32%
Q1 Forecast
1.41

Autolus Therapeutics Ltd reported $22.61M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AstraZeneca USD 15.5B 313M Dec/2025
Autolus Therapeutics Ltd USD 22.61M 1.71M Sep/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Novartis USD 13.91B 144M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Silence Therapeutics USD 39K 120K Mar/2026